Cargando…

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment

CONTEXT: Trans women (male sex assigned at birth, female gender identity) mostly use antiandrogens combined with estrogens and can subsequently undergo vaginoplasty including orchiectomy. Because the prostate remains in situ after this procedure, trans women are still at risk for prostate cancer. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Nie, Iris, de Blok, Christel J M, van der Sluis, Tim M, Barbé, Ellis, Pigot, Garry L S, Wiepjes, Chantal M, Nota, Nienke M, van Mello, Norah M, Valkenburg, Noelle E, Huirne, Judith, Gooren, Louis J G, van Moorselaar, R Jeroen A, Dreijerink, Koen M A, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379905/ https://www.ncbi.nlm.nih.gov/pubmed/32594155 http://dx.doi.org/10.1210/clinem/dgaa412

Ejemplares similares

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
por: de Blok, Christel JM., et al.
Publicado: (2021)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)
por: Dijkman, Benthe A M, et al.
Publicado: (2023)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Transgender Girls Grow Tall: Adult Height Is Unaffected by GnRH Analogue and Estradiol Treatment
por: Boogers, Lidewij Sophia, et al.
Publicado: (2022)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2019)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

Surgical outcomes and proposal for a treatment algorithm for urethral strictures in transgender men
por: de Rooij, Freek P. W., et al.
Publicado: (2021)

Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women
por: de Nie, I, et al.
Publicado: (2021)

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
por: Sridhar, Amrutha, et al.
Publicado: (2023)

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
por: van der Sluis, Inge M., et al.
Publicado: (2022)

PB2408: PREVALENCE OF METABOLIC SYNDROME IN LONG TERM HEMATOPOIETIC STEM CELL TRANSPLANTATION SURVIVORS: COMPARISON WITH A MATCHED REFERENCE COHORT.
por: van Yperen, Nicole, et al.
Publicado: (2023)

Comparison of surgical outcomes and urinary functioning after phalloplasty with versus without urethral lengthening in transgender men
por: de Rooij, Freek P. W., et al.
Publicado: (2022)

EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
por: Schotten, Nienke, et al.
Publicado: (2017)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

PB1793: NEUTROPHIL TO LYMPHOCYTE RATIO AS A PROGNOSTIC FACTOR IN AML AND MDS
por: Van Oorschot, V., et al.
Publicado: (2022)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Surgical outcomes of testicular prostheses implantation in transgender men with a history of prosthesis extrusion or infection
por: Legemate, Catherine M., et al.
Publicado: (2020)

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2019)

Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
por: Schröder, Mariska A M, et al.
Publicado: (2021)

PB1706: ABL-CLASS GENOMIC BREAKPOINT Q-PCR FOR RELIABLE MEASURABLE RESIDUAL DISEASE MONITORING IN ALL PATIENTS
por: van Outersterp, Inge, et al.
Publicado: (2023)

PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
por: Monard, Amaury, et al.
Publicado: (2023)

IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
por: Joustra, Sjoerd D, et al.
Publicado: (2019)

Surgical management of a perforated ‘black oesophagus’
por: Kuiper, Gino M., et al.
Publicado: (2021)

Serum Inflammation-based Scores in Endocrine Tumors
por: Marques, Pedro, et al.
Publicado: (2021)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
por: Zimmerman, Yvette, et al.
Publicado: (2022)

Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery – A Case Series and Literature Overview
por: Asseler, Joyce D., et al.
Publicado: (2021)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands
por: de Ridder, Maria A J, et al.
Publicado: (2022)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

Impaired semen quality in trans women: prevalence and determinants
por: de Nie, I, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rk611b88gdp1551j3gqcamtkgn